Back To: Home



June 6-7, 2013
European Lab Automation - Hamburg, Germany

June 12-15, 2013

More Events
Name:
Company:
Email:
 
 
 
Transfect with Confidence. Roche X-tremeGENE Transfection Reagents

ACADIA, Allergan extend ophthalmic collaboration
April 2012
SHARING OPTIONS:

SAN DIEGO—ACADIA Pharmaceuticals Inc. announced the extension of its drug discovery and development collaboration with Allergan Inc., which began in March 2003. The collaboration, which is centered on the discovery of therapeutics for glaucoma and other ophthalmic indications, has been extended one year to go through March 2013. During the extension period, Allergan and ACADIA will jointly pursue ophthalmic research. Allergan is entitled to exclusively license specific chemistry and related assets for development and commercialization, and ACADIA will receive research funding as well as potential license fees and milestone payments if certain agreed-upon clinical and regulatory milestones are met. ACADIA also stands to receive royalties on worldwide future product sales. The companies have two other collaboration agreements in effect, which have progressed to clinical programs in chronic pain and glaucoma.

Back

cISBIO

ATCC


Beckman

ISSCR

INDIGO

European Lab Automation
CONTACT US
Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2013 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.